Gangneung, South Korea

Soon Kwang Lee

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Korea Institute of Science and Technology, Yonsei University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soon Kwang Lee. Retrieved from https://idiyas.com/inventor/soon-kwang-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Soon Kwang Lee in Cancer Treatment

Introduction

Soon Kwang Lee is a notable inventor based in Gangneung, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on developing compositions that utilize natural extracts for therapeutic purposes.

Latest Patents

Soon Kwang Lee holds a patent for "Compositions for preventing or treating cancer comprising extracts of var. (Nakai) T.B. Lee." This patent outlines compositions that include extracts from var. tozawai (Nakai) T.B. Lee as an active ingredient. The extract has demonstrated excellent anticancer efficacy against various cancers, including diffuse-type gastric cancer. This innovation holds promise for developing effective cancer treatment agents.

Career Highlights

Throughout his career, Soon Kwang Lee has been associated with prestigious institutions such as the Korea Institute of Science and Technology and Yonsei University. His work at these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Soon Kwang Lee's innovative work in cancer treatment showcases the potential of natural extracts in medical applications. His contributions are paving the way for new therapeutic options in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…